Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 2/20 | 0.41 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.39 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.39 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.39 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | DPP4 | P27487 | 2/20 | 0.37 |
| ▸ | F2 | P00734 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3668659 | 0.82 | DPP4 (0.40) | SLC6A4AOC3SLC6A2SLC6A3ADRA2A | |
| SCHEMBL28774583 | 0.79 | SLC6A4 (0.41) | SLC6A4AOC3LMNARIPK1ALDH1A1 | |
| SCHEMBL6438147 | 0.78 | CYP2C19 (0.44) | SLC6A4AOC3LMNARIPK1 | |
| SCHEMBL18897402 | 0.77 | SLC6A4 (0.42) | SLC6A4AOC3SLC6A2SLC6A3RIPK1 | |
| SCHEMBL10213399 | 0.77 | SLC6A4 (0.42) | SLC6A4AOC3SLC6A2SLC6A3RIPK1 | |
| SCHEMBL9577935 | 0.76 | AOC3 (0.57) | SLC6A4AOC3SLC6A2SLC6A3ADRA2A | |
| SCHEMBL3367523 | 0.76 | ADRA2A (0.45) | SLC6A4AOC3SLC6A2SLC6A3ADRA2A | |
| SCHEMBL20827946 | 0.75 | SLC6A4 (0.41) | SLC6A4AOC3SLC6A3ADRA2CRIPK1 | |
| SCHEMBL23723006 | 0.71 | CYP2D6 (0.40) | LMNAHIF1A | |
| SCHEMBL10599811 | 0.71 | AOC3 (0.52) | SLC6A4AOC3SLC6A2SLC6A3ADRA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190248956-A1 | POLY(L-LYSINE ISOLPHTHALAMIDE) (PLP) POLYMERS WITH HYDROPHOBIC PENDANT CHAINS | IMPERIAL INNOVATIONS LIMITED (GB) | 2019-08-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190248956-A1 | POLY(L-LYSINE ISOLPHTHALAMIDE) (PLP) POLYMERS WITH HYDROPHOBIC PENDANT CHAINS | PLP2, LNPEP, PLPBP | SLC6A4 3280/4885AOC3 4393/4885SLC6A2 3440/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.